Skip to content

Malignant chapters

About this audiobook · Recording details

Recording vinayak-k-prasad-2020 · Narrated by Vinayak K. Prasad

20 chapters

Chapter titles and times
ChapterTitleStartDuration
1Opening Credits0:00:000:00:18.018
2Introduction0:00:18.0180:16:44.959
3Chapter 1: The Basics of Cancer Drugs: Cost, Benefit, Value0:17:02.9770:23:23.112
4Chapter 2: Surrogate Endpoints in Cancer: What Are They and Where Are They Used?0:40:26.0890:25:43.616
5Chapter 3: The Use and Misuse of Surrogate Endpoints for Drug Approvals1:06:09.7050:28:11.457
6Chapter 4: How High Prices Harm Patients and Society1:34:21.1620:22:13.452
7Chapter 5: Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine1:56:34.6140:20:26.547
8Chapter 6: Financial Conflict of Interest2:17:01.1610:23:20.720
9Chapter 7: The Harms of Financial Conflicts and How to Rehabilitate Medicine2:40:21.8810:24:30.148
10Chapter 8: Will Precision Oncology Save Us?3:04:52.0290:17:38.620
11Chapter 9: Study Design 2013:22:30.6490:38:41.693
12Chapter 10: Principles of Oncology Practice4:01:12.3420:26:51.046
13Chapter 11: Important Trials in Oncology4:28:03.3880:34:58.619
14Chapter 12: Global Oncology5:03:02.0070:26:19.769
15Chapter 13: How Should Cancer Drug Development Proceed?5:29:21.7760:33:57.783
16Chapter 14: What Can Three Federal Agencies Do Tomorrow?6:03:19.5590:37:09.719
17Chapter 15: What Can People with Cancer Do?6:40:29.2780:16:57.196
18Chapter 16: What Can Students, Residents, and Fellows Do?6:57:26.4740:13:13.681
19Epilogue: The Hallmarks of Successful Cancer Policy7:10:40.1550:13:04.207
20End Credits7:23:44.3620:00:14.093